| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AMERICAN GROWTH FD OF AMERICA | 109,045 | 185,090 |
| CAPITAL WORLD GROWTH & INCOME | 190,521 | 332,998 |
| PROSHARES TRUST | 1,232,460 | 579,875 |
| XENOPORT, INC. | 8,006 | 6,990 |
| ZS PHARMA INC COM | 345,979 | 3,504,392 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| ENABLE INJECTIONS, LLC | 168,807 | 2,236,590 | |
| NEURONETICS, INC CONVERTIBLE N | 533,884 | 533,884 | |
| NEURONETICS, INC. SER. D PFD | 125,000 | 102,459 | |
| NEURONETICS, INC. SER. E PFD | 300,000 | 300,000 | |
| PERCEPTIS MEDICAL SERIES A PRE | 250,000 | 250,000 | |
| SKYLINE VENTURE PARTNERS III, | 28,800 | ||
| SUREFIRE MEDICAL SERIES B-1 PR | 1,000,000 | 999,999 | |
| SUREFIRE MEDICAL SERIES B-2 PR | 1,500,001 | 1,500,000 | |
| SUREFIRE SERIES A PREFERRED ST | 805,000 | 107,881 | |
| USVP ENTREPRENEUR PARTNERS VII | 65,802 | 61,460 | |
| ZUREX PHARMA, INC SERIES A PRE | 200,000 | 95,658 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| General Consultations | 1,890 | 1,890 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Administrative Fees | 34,036 | 34,036 | ||
| K-1 Exp ENABLE INJECTIONS, LLC | 640 | |||
| K-1 Exp SKYLINE VENTURE QUALIF | 95 | 95 | ||
| K-1 Exp USVP ENTREPRENEUR PART | 1,667 | 1,667 | ||
| State or Local Filing Fees | 61 | 61 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| K-1 Inc/Loss ENABLE INJECTIONS, LLC | -40,955 | -40,955 | |
| K-1 Inc/Loss ENABLE UROLOGY, LLC | -489 | -489 | |
| K-1 Inc/Loss SALEM ZS INVESTORS LLC | -235 | -235 | |
| K-1 Inc/Loss SKYLINE VENTURE PARTNERS III, L.P. | 1 | 1 | |
| K-1 Inc/Loss SKYLINE VENTURE QUALIFIED PURCHASERS | 25 | 25 | |
| K-1 Inc/Loss USVP ENTREPRENEUR PARTNERS VIII-B, LP | 27 | 27 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PHILANTHROPIC CONSULTING FEES | 12,000 | 12,000 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 990-PF Estimated Tax for 2014 | 20,200 | |||
| 990-PF Extension for 2013 | 6,954 |